Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxygenases from pig liver microsomes

References

• Barrowman M. M., Marriner S. E., Bogan J. A. The binding and subsequent inhibition of tubulin polymerisation in ascaris suum (in vitro) by benzimidazole anthelmintics. Biochemical Pharmacology 1984; 33: 3037–3040
   PubMed Web of Science ®Google Scholar
• Damani L. A. Metabolism of sulfur containing drugs. 10th European Drug Metabolism Workshop. 1986; 9, Guildford (GB), Abstract L18, p.
   Google Scholar
• Delatour P., Parish R. C., Gyurik R. J. Albendazole: a comparison of relay embryotoxicity with embryotoxicity of individual metabolites. Annales de Recherche Vétérinaire 1981; 12: 159–167
   PubMedGoogle Scholar
• Delatour P., Garnier F., Benoit E., Longin C. A correlation of toxicity of albendazole and oxfendazole with their free metabolites and bound residues. Journal of Veterinary Pharmacology and Therapeutics 1984; 7: 139–145
   PubMed Web of Science ®Google Scholar
• Douch P. G. L., Buchanan L. L. Some properties of sulfoxidases and sulfoxide reductases of the cestode Monieza expansa, the nematode Ascaris suum and mouses liver. Xenobiotica 1979; 9: 675–679
   PubMed Web of Science ®Google Scholar
• Fargetton X., Galtier P., Delatour P. Sulfoxidation of albendazole by a cytochrome P-450-independent monooxygenase from rat liver microsomes. Veterinary Research Communications 1986; 10: 317–324
   PubMed Web of Science ®Google Scholar
• Faure A., Nemoz C., Fargetton X. Computerized method for determination of Km and Vmax values from measures of enzymatic activities with end point method. Computer Programs in Biomedicine 1986; 22: 163
   Google Scholar
• Galtier P., Alvinerje M., Delatour P. In vitro sulfoxidation of albendazole by bovine liver microsomes. American Journal of Veterinary Research 1986; 47: 447–450
   PubMed Web of Science ®Google Scholar
• Gyurik R. J., Chow A. W., Zaber B., Bruner E. L., Miller J. A., Villani A. J., Petka L. A., Parish R. C. Metabolism of albendazole in cattle, sheep, rats and mice. Drug Metabolism and Disposition 1981; 19: 503–508
   Google Scholar
• Hajjar N. P., Hodgson E. Flavine adenine dinucleotide, dependent monooxygenase: its role in the sulfoxidation of pesticides in mammals. Science 1980; 209: 1134–1136
   PubMed Web of Science ®Google Scholar
• Ivanetich K. H., Costa A. K., Brittain T. Limitations on the metyrapone assay for the major phenobarbital inducible form of cytochrome P-450. Biochemical and Biophysical Communications 1982; 105: 1322–1326
   PubMedGoogle Scholar
• Jefcoate C. R. E., Gaylor G. L., Calabrese R. L. Ligand interaction with cytochrome P-450. I. binding of primary amine. Biochemistry 1980; 8: 3455–3463
   Google Scholar
• Kamataki T., Sugiuna M., Yamazoe Y., Kato R. Purification and properties of cytochrome P-450 and NADPH-cytochrome C (P-450) reductase from human liver microsomes. Biochemical Pharmacology 1993; 28, 2000
   Google Scholar
• Kedderis G. L., Rickert D. E. Loss of rat microsomal cytochrome P-450 during methimazole metabolism: Role of flavin containing monooxygenase. Drug Metabolism and Disposition 1985; 13: 58–61
   PubMed Web of Science ®Google Scholar
• Kitchell B. B., Rauckman E. S., Rosen G. M. The effect of temperature on mixed function amine oxidase intrinsic fluorescence and oxidative activity. Molecular Pharmacology 1978; 14: 1092–1098
   PubMed Web of Science ®Google Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 272: 680–685
   Google Scholar
• Le Provost E., Flinois J. P., Beaune Ph., Leroux J. P. Immunochemical characterization of some monooxyenase activities in liver microsomes from untreated and phenobarbital-treated rats. Biochemical and Biophysical Research Communications 1981; 101: 547–554
   PubMedGoogle Scholar
• Lesca P., Lecointe P., Paoletti C., Mansuy D. Ellipticines as potent inhibitors of arylhydrocarbon hydroxylase: Their binding to microsomal cytochromes P-450 and protective effect against benzo[a]pyrene mutagenicity. Biochemical Pharmacology 1978; 27: 1203–1209
   PubMed Web of Science ®Google Scholar
• Mazel P. Experiments illustrating drug metabolism in vitro. Fundamentals of drug metabolism and drug disposition, B. N. La Du, H. G. Mandel, E. L. Way. Waverley Press Inc., Baltimore, USA 1971; 546–582
   Google Scholar
• Marriner S. E., Bogan J. A. Pharmacokinetics of albendazole in sheep. American Journal of Veterinary Research 1980; 41: 1126–1129
   PubMed Web of Science ®Google Scholar
• Mitchell S. C., Waring R. H. The early history of xenobiotic sulfoxidation. Drug Metabolism Reviews 1986; 16: 255–284
   Google Scholar
• Netter K. J., Seidel B. L. An adaptively stimulated O-demethylating system in rat liver microsomes and its kinetic properties. Journal of Pharmacology and Experimental Therapeutics 1964; 146: 61–65
   PubMed Web of Science ®Google Scholar
• Oae S., Mikami A., Matsuura T., Ogawa-Asada K., Watanabe Y., Fujimori K., Iyanagi T. Comparison of sulfide oxygenation mechanism for liver microsomal FAD-containing monooxygenase with that for cytochrome P-450. Biochemical and Biophysical Research Communications 1985; 131: 567–573
   PubMed Web of Science ®Google Scholar
• Penicaut B., Maugein P. H., Maisonneuve H., Rossignol J. F. Pharmacocinétique et metabolisme urinaire de l'albendazole chez l'homme. Bulletin de le Société Pathologie Expérimentale 1983; 76: 698–708
   PubMed Web of Science ®Google Scholar
• Poulsen L. L., Hyslop R. M., Ziegler D. M. S.oxygenation of N. substituted thioureas catalysed by the pig liver microsomal FAD-containing monooxygenase. Archives of Biochemistry and Biophysics 1979; 198: 78–88
   PubMed Web of Science ®Google Scholar
• Prichard R. K., Henessy D. R., Steel J. N., Lacey E. Metabolite concentrations in plasma following treatment of cattle with five anthelmintics. Research Veterinary Science 1985; 39: 173–178
   PubMed Web of Science ®Google Scholar
• Prough A. R., Ziegler D. M. The relative participation of liver microsomal amine oxidase and cytochrome P-450 in N-demethylation reactions. Archives of Biochemistry and Biophysics 1977; 180: 363–373
   PubMed Web of Science ®Google Scholar
• Saimot A. G., Crémieux A. C., Hay J. M., Meulemans A., Giovanangeli M. D., Delaitre B., Coulaud J. P. Albendazole as a potential treatment for human hydatidosis. The Lancet 1983; 17: 652–656
   Google Scholar
• Schenkman J. B. S. Studies on the nature of Type I and Type II spectral changes in liver microsomes. Biochemistry 1970; 9: 2081–3011
   PubMed Web of Science ®Google Scholar
• Theodorides V. J., Gyurik R. J., Kingsbury W. D., Parish R. C. Anthelmintic activity of albendazole against liver flukes, tapeworms lung and gastrointestinal roundworms. Experimentia 1976; 32: 702–703
   PubMedGoogle Scholar
• Tynes R. E., Hodgson E. Oxidation of thiobenzamide by the FAD containing and cytochrome P-450 dependent monooxygenase of liver and lung microsomes. Biochemical Pharmacology 1983; 32: 3419–3428
   PubMed Web of Science ®Google Scholar
• Ullrich V., Weber P. The O-dealkylation of 7-ethoxycoumarin by liver microsomes: a direct fluorimetric assay. Hoppe Seyler's Zeitschrift für Physiologie und Chemie 1972; 353: 1171–1177
   PubMedGoogle Scholar
• Yang C. S., Strickhart F. S. Inhibition of hepatic mixed function oxidase activity by propylgallate. Biomedical Pharmacology 1974; 23: 3129–3138
   Google Scholar
• Yasukochi Y., Masters B. S. S. Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. Journal of Biological Chemistry 1976; 251: 5337–5344
   PubMed Web of Science ®Google Scholar
• Ziegler D. M. Microsomal flavin containing monooxygenase, oxygenation of nucleophilic nitrogen and sulfur containing compounds. Enzymatic Basis of Detoxification, W. B. Jakoby. Academic Press, New York 1980; 201–227
   Google Scholar